Terry Kearney

Insider profile

Currently holds positions in Vertex Pharmaceuticals Incorporated and Acceleron Pharma Inc

Positions

Position Company Period
Independent Director Vertex Pharmaceuticals Incorporated May 17, 2011 -
Independent Director Acceleron Pharma Inc July 14, 2014 -
Independent Director AveXis Inc Jan. 1, 2016 - May 15, 2018
Independent Director Innoviva Inc Oct. 30, 2014 - April 26, 2016
Terry Kearney's trades of Vertex Pharmaceuticals Incorporated's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
328.66
Quantity 9,787 +16.5%
Value US$1,172,939
Transaction date
Planned sale
Price
119.78
Quantity 16,210 -72.9%
Value US$1,941,634
Transaction date
Planned sale
Price
119.11
Quantity 18,177 -45.0%
Value US$2,165,062
Transaction date
Planned sale
Price
117.82
Quantity 2,200 -5.2%
Value US$259,204
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-14 2023-08-10
PlS Planned sale
58,812 -30.6%
248.26
US$557,854 		58,812 -30.6% 248.26 US$557,854
2023-08-10 2023-08-10
PrS Proposed sale
67,366
468.91
US$2,845,692 		67,366 468.91 US$2,845,692
2020-10-13 2020-10-12
PlS Planned sale
9,787 +16.5%
328.66
US$1,172,939 		9,787 +16.5% 328.66 US$1,172,939
2020-10-13 2020-10-12
PlS Planned sale
16,210 -72.9%
119.78
US$1,941,634 		16,210 -72.9% 119.78 US$1,941,634
2020-10-13 2020-10-12
PlS Planned sale
18,177 -45.0%
119.11
US$2,165,062 		18,177 -45.0% 119.11 US$2,165,062
2020-10-13 2020-10-12
PlS Planned sale
2,200 -5.2%
117.82
US$259,204 		2,200 -5.2% 117.82 US$259,204